Universal Charcoal with Aloe Vera Anti-Cavity Fluoride

Description

Universal Charcoal with Aloe Vera Anti-Cavity Fluoride Toothpaste is formulated to provide effective oral care. This toothpaste combines the properties of activated charcoal and aloe vera, aimed at promoting dental health while preventing cavities. The inclusion of fluoride enhances its efficacy in strengthening tooth enamel and reducing the risk of decay. The product is designed for daily use, contributing to overall oral hygiene.

Uses and Indications

This drug is indicated for the management of painful sensitivity of teeth associated with cold, heat, acids, and sweets. It builds increasing protection against such sensitivity, providing relief for affected individuals.

Additionally, this drug aids in the prevention of dental cavities, contributing to overall oral health.

Dosage and Administration

For adults and children aged 12 years and older, a minimum of a 1-inch strip of the product should be applied onto a soft bristle toothbrush. Patients are instructed to brush their teeth thoroughly for at least 1 minute, twice daily (morning and evening). Brushing may occur up to three times a day, or as directed by a dentist or physician. It is essential to ensure that all sensitive areas of the teeth are brushed, while minimizing swallowing. After brushing, the product should be expectorated.

For children under 12 years of age, it is recommended to consult a dentist or physician prior to use.

Contraindications

There are no specific contraindications identified for this product. However, the following precautions should be observed:

• Keep out of reach of children to prevent accidental ingestion.

• In the event of accidental swallowing while brushing, seek professional assistance or contact a Poison Control Center immediately.

• If symptoms persist or worsen, consult a dentist, as sensitivity in teeth may indicate a serious underlying issue requiring prompt dental care.

Warnings and Precautions

Warning: This product should be used with caution.

General precautions must be observed to ensure safety. It is imperative to keep this product out of reach of children. In the event of accidental ingestion while brushing, immediate professional assistance should be sought, or the local Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult a dentist if symptoms persist or worsen. Notably, sensitivity in teeth may signify a serious underlying issue that requires prompt dental evaluation. If pain or sensitivity continues after four weeks of use, patients are strongly encouraged to visit their dentist for further assessment and care.

Side Effects

Patients may experience adverse reactions that warrant attention. It is important for patients to be aware of any sensitivity in their teeth, as this may indicate a serious underlying issue that requires prompt care by a dentist.

In the event that sensitivity persists or worsens, patients are advised to stop using the product and consult a dentist for further evaluation and management. This precaution is essential to ensure that any potential dental problems are addressed in a timely manner.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Universal Charcoal with Aloe Vera Anti-Cavity Fluoride (sodium fluoride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should be advised to consult a dentist or doctor prior to use. This recommendation is essential to ensure appropriate evaluation and guidance regarding treatment options for this age group.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be advised to discuss their pregnancy status and any plans for pregnancy with their healthcare provider prior to initiating treatment.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is essential that patients with reduced creatinine clearance are closely monitored to ensure safety and efficacy. Regular renal function tests should be performed in patients with kidney problems to assess their condition. A reduced dose is recommended for patients with moderate to severe renal impairment to mitigate the risk of adverse effects.

Hepatic Impairment

Patients with hepatic impairment may experience altered metabolism of the drug, necessitating dosage adjustments to ensure safety and efficacy. It is essential to monitor liver function tests regularly in this patient population to assess the impact of hepatic function on drug metabolism and to guide any necessary modifications in therapy. Special precautions should be taken when prescribing to patients with compromised liver function, considering the potential for increased risk of adverse effects and the need for careful management of dosing regimens.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, specific antidotes or treatments may be indicated based on the substance involved in the overdose. Consultation with a poison control center or a medical toxicologist is recommended to guide the management of the patient effectively.

Overall, vigilance and prompt intervention are critical in managing cases of suspected overdose, even in the absence of detailed information regarding specific overdosage effects.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is accidentally swallowed while brushing, they should seek professional help or contact a Poison Control Center immediately.

Patients should be informed that if they experience persistent or worsening issues while using the product, they should stop use and consult a dentist. It is important to communicate that sensitivity in teeth may indicate a serious underlying problem that requires prompt dental care.

Additionally, healthcare providers should emphasize that if pain or sensitivity continues after four weeks of use, patients should visit their dentist for further evaluation and care.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a cool, dry place to maintain its integrity and effectiveness. Proper storage conditions are crucial to ensure the product remains within its specified temperature range and is protected from moisture.

Additional Clinical Information

The product is administered via the dental route. For adults and children aged 12 years and older, a minimum of a 1-inch strip should be applied to a soft bristle toothbrush, with thorough brushing for at least 1 minute twice daily, not exceeding three times a day unless directed by a dentist or doctor. For children under 12 years of age, consultation with a dentist or doctor is advised.

Clinicians should counsel patients to seek dental advice if pain or sensitivity persists after four weeks of use, or if symptoms worsen. It is important to inform patients that sensitivity may indicate a serious dental issue requiring prompt attention. Additionally, the product should be kept out of reach of children, and in the event of accidental ingestion while brushing, professional help or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Universal Charcoal with Aloe Vera Anti-Cavity Fluoride, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)